NCT00052923View on ClinicalTrials.gov

Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma

PHASE3CompletedINTERVENTIONAL

Enrollment

427

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

June 30, 2006

Conditions

Lymphoma

Interventions

BIOLOGICAL

filgrastim

BIOLOGICAL

rituximab

DRUG

carmustine

DRUG

cyclophosphamide

DRUG

etoposide

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

Cancer and Leukemia Group B

NETWORK

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00052923 - Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma | Biotech Hunter | Biotech Hunter